Givaudan reports 8.60 percent growth while Givaudan stock costs EUR 4,290.50

Published on 10/22/2026 at 12:10 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Nine-month sales reached CHF 5.891 billion on October 13, 2026, up 5.20 percent LFL. Givaudan stock costs EUR 4,290.50 on October 22, 2026.

Sales growth and investor dates

Third-quarter like-for-like sales grew 8.60 percent on October 13, 2026.
Givaudan targets 4.00 percent to 6.00 percent average annual sales growth through 2030.
Givaudan stock was trading at EUR 4,290.50 at 12:05 p.m. CEST at Lang & Schwarz on October 22, 2026.

A soft watercolour painting of a vast lavender field in full bloom. Neat violet rows stretch to the horizon where snow-capped Swiss Alpine peaks rise in muted blue-grey silhouette. The sky is painted in gentle washes of peach and pale blue. Loose wet-on-w — Givaudan CH0010645932 Aquarell eines Lavendelfeldes vor stiller Schweizer Alpen-Silhouette in zarten Pastelltönen, Illustration mit AI erstellt.

Givaudan (CH0010645932) recorded CHF 5.891 billion in sales in the first nine months of 2026, up 5.20 percent on a like-for-like basis. The company published the figures on October 13, 2026, in its official nine-month sales release. The acceleration in the third quarter gives investors a clearer test of whether the fragrance recovery can offset weaker momentum in Taste & Wellbeing.

What did the third quarter show?

Givaudan's third-quarter sales rose 8.60 percent on a like-for-like basis and reached CHF 2.092 billion on a reported basis. According to Reuters on October 13, 2026, the result exceeded the company-compiled consensus of 4.70 percent like-for-like growth.

Fragrance & Beauty was the main contributor, with like-for-like sales growth of 13.50 percent in the quarter versus 6.60 percent expected by analysts. Taste & Wellbeing grew 3.50 percent on the same basis, ahead of the 2.80 percent consensus, although the division remains the slower part of the portfolio.

Can the growth continue?

The company maintained its medium- and long-term targets in the release, including average annual like-for-like sales growth of 4.00 percent to 6.00 percent and an average adjusted free cash flow margin above 12.00 percent through 2030. Those targets give the strong quarter a longer-term benchmark rather than treating it as a stand-alone result.

Analyst views remain mixed after the update. Markets Insider reported on October 14, 2026, that JPMorgan raised its target from CHF 3,700 to CHF 4,100 and kept an Overweight rating. By contrast, Bernstein maintained a Sell rating with a CHF 3,004 target on October 20, 2026, according to the same published analyst update.

Which dates come next?

Givaudan lists an investor presentation in Zurich for October 29, 2026, according to its investor-relations calendar. The company is scheduled to publish full-year 2026 results on January 27, 2027, according to the reported earnings calendar.

Stock price and investor view

The nine-month figures put the fragrance division at the center of the investment case, while the slower Taste & Wellbeing performance remains a counterweight. The next investor presentation on October 29, 2026, may provide further detail on volume trends and the path toward the 2030 targets.

Givaudan was trading at EUR 4,290.50 at Lang & Schwarz on October 22, 2026 at 12:05 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Givaudan stock.